Circulating visfatin in chronic obstructive pulmonary disease

Nutrition

Volumn 25, Issue 4, 2009, Pages 373-378

  Liu, Xiaojing ^a   Ji, Yulin ^a   Chen, Jian ^a   Li, Shuangqing ^a   Luo, Fengming ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Chronic obstructive pulmonary disease; Systemic inflammation; Visfatin

Indexed keywords

ADIPOCYTOKINE; C REACTIVE PROTEIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

AGED; ARTICLE; BIOENERGY; BODY COMPOSITION; BODY FAT; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; HUMAN; IMPEDANCE; MALE; NUTRITIONAL STATUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPOSE TISSUE; AGED; BIOLOGICAL MARKERS; BODY COMPOSITION; BODY MASS INDEX; C-REACTIVE PROTEIN; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 60749115555     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nut.2008.09.008     Document Type: Article

References (30)

1. Hallin R., Gudmundsson G., Suppli Ulrik C., Nieminen M.M., Gislason T., Lindberg E., et al. Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD). Respir Med (2007) (in press)
2. Alcolea Batres S., Villamor Leon J., and Alvarez-Sala R. Nutritional status in COPD. Arch Bronconeumol 43 (2007) 283-288
3. Shore S.A. Obesity and asthma: cause for concern. Curr Opin Pharmacol 6 (2006) 230-236
4. Luo F.M., Liu X.J., Li S.Q., Wang Z.L., Liu C.T., and Yuan Y.M. Circulating ghrelin in patients with chronic obstructive pulmonary disease. Nutrition 21 (2005) 793-798
5. Nagaya N., Itoh T., Murakami S., Oya H., Uematsu M., Miyatake K., and Kangawa K. Treatment of cachexia with ghrelin in patients with COPD. Chest 128 (2005) 1187-1193
6. Jia S.H., Li Y., Parodo J., Kapus A., Fan L., Rotstein O.D., and Marshall J.C. Pre-B cell colony-enhancing factor inhibits neutrophil apoptosis in experimental inflammation and clinical sepsis. J Clin Invest 113 (2004) 1318-1327
7. Ye S.Q., Zhang L.Q., Adyshev D., Usatyuk P.V., Garcia A.N., Lavoie T.L., et al. Pre-B-cell-colony-enhancing factor is critically involved in thrombin-induced lung endothelial cell barrier dysregulation. Microvasc Res 70 (2005) 142-151
8. Bajwa E.K., Yu C.L., Gong M.N., Thompson B.T., and Christiani D.C. Pre-B-cell colony-enhancing factor gene polymorphisms and risk of acute respiratory distress syndrome. Crit Care Med 35 (2007) 1290-1295
9. Haider D.G., Schindler K., Schaller G., Prager G., Wolzt M., and Ludvik B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab 91 (2006) 1578-1581
10. Fernandez-Real J.M., Moreno J.M., Chico B., Lopez-Bermejo A., and Ricart W. Circulating visfatin is associated with parameters of iron metabolism in subjects with altered glucose tolerance. Diabetes Care 30 (2007) 616-621
11. Krzyzanowska K., Mittermayer F., Krugluger W., Kopp H.P., and Schernthaner G. Increase in visfatin after weight loss induced by gastroplastic surgery. Obesity (Silver Spring) 14 (2006) 1886-1889
12. Axelsson J., Witasp A., Carrero J.J., Qureshi A.R., Suliman M.E., Heimburger O., et al. Circulating levels of visfatin/pre-B-cell colony-enhancing factor 1 in relation to genotype, GFR, body composition, and survival in patients with CKD. Am J Kidney Dis 49 (2007) 237-244
13. Lopez-Bermejo A., Chico-Julia B., Fernandez-Balsells M., Recasens M., Esteve E., Casamitjana R., et al. Serum visfatin increases with progressive beta-cell deterioration. Diabetes 55 (2006) 2871-2875
14. Zheng J., and Zhong N. Normative values of pulmonary function testing in Chinese adults. Chin Med J (Engl) 115 (2002) 50-54
15. Körner A., Garten A., Bluher M., Tauscher R., Kratzsch J., and Kiess W. Molecular characteristics of serum visfatin and differential detection by immunoassays. J Clin Endocrinol Metab 92 (2007) 4783-4791
16. Berndt J., Kloting N., Kralisch S., Kovacs P., Fasshauer M., Schon M.R., et al. Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes 54 (2005) 2911-2916
17. Kowalska I., Straczkowski M., Nikolajuk A., Adamska A., Karczewska-Kupczewska M., Otziomek E., et al. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome. Hum Reprod 22 (2007) 1824-1829
18. Zahorska-Markiewicz B., Olszanecka-Glinianowicz M., Janowska J., Kocelak P., Semik-Grabarczyk E., Holecki M., et al. Serum concentration of visfatin in obese women. Metabolism 56 (2007) 1131-1134
19. Filippatos T.D., Derdemezis C.S., Kiortsis D.N., Tselepis A.D., and Elisaf M.S. Increased plasma levels of visfatin/pre-B cell colony-enhancing factor in obese and overweight patients with metabolic syndrome. J Endocrinol Invest 30 (2007) 323-326
20. Kralisch S., Klein J., Lossner U., Bluher M., Paschke R., Stumvoll M., and Fasshauer M. Hormonal regulation of the novel adipocytokine visfatin in 3T3-L1 adipocytes. J Endocrinol 185 (2005) R1-R8
21. Hector J., Schwarzloh B., Goehring J., Strate T.G., Hess U.F., Deuretzbacher G., et al. TNF-alpha alters visfatin and adiponectin levels in human fat. Horm Metab Res 39 (2007) 250-255
22. Ognjanovic S., Bao S., Yamamoto S.Y., Garibay-Tupas J., Samal B., and Bryant-Greenwood G.D. Genomic organization of the gene coding for human pre-B-cell colony enhancing factor and expression in human fetal membranes. J Mol Endocrinol 26 (2001) 107-117
23. Ye S.Q., Simon B.A., Maloney J.P., Zambelli-Weiner A., Gao L., Grant A., et al. Pre-B-cell colony-enhancing factor as a potential novel biomarker in acute lung injury. Am J Respir Crit Care Med 171 (2005) 361-370
24. Moschen A.R., Kaser A., Enrich B., Mosheimer B., Theurl M., Niederegger H., and Tilg H. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J Immunol 178 (2007) 1748-1758
25. Bae S.K., Kim S.R., Kim J.G., Kim J.Y., Koo T.H., Jang H.O., et al. Hypoxic induction of human visfatin gene is directly mediated by hypoxia-inducible factor-1. FEBS Lett 580 (2006) 4105-4113
26. Semenza G.L. Pulmonary vascular responses to chronic hypoxia mediated by hypoxia-inducible factor 1. Proc Am Thorac Soc 2 (2005) 68-70
27. Otero M., Lago R., Gomez R., Lago F., Dieguez C., Gomez-Reino J.J., and Gualillo O. Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 65 (2006) 1198-1201
28. Pletz M.W., and Lode H. Apoptosis of circulating neutrophils in COPD patients. Chest 127 (2005) 1464-1465
29. Pilz S., Mangge H., Obermayer-Pietsch B., and Marz W. Visfatin/pre-B-cell colony-enhancing factor: a protein with various suggested functions. J Endocrinol Invest 30 (2007) 138-144
30. Krzysik-Walker S.M., Ocon-Grove O.M., Maddineni S.R., Hendricks III G.L., and Ramachandran R. Is visfatin an adipokine or myokine?. Evidence for greater visfatin expression in skeletal muscle than visceral fat in chickens. Endocrinology 149 (2008) 1543-1550